Tandem mass spectrometry identification and LC-MS quantification of intact cytokinin nucleotides in K-562 human leukemia cells

0351018 - ÚEB 2011 RIV DE eng J - Článek v odborném periodiku
Béres, Tibor - Zatloukal, Marek - Voller, Jiří - Niemann, P. - Gahsche, M.C. - Tarkowski, Petr - Novák, Ondřej - Hanuš, Jan - Strnad, Miroslav - Doležal, Karel
Tandem mass spectrometry identification and LC-MS quantification of intact cytokinin nucleotides in K-562 human leukemia cells.
Analytical and Bioanalytical Chemistry. Roč. 398, č. 5 (2010), s. 2071-2080. ISSN 1618-2642. E-ISSN 1618-2650
Grant CEP: GA MŠMT 1M06030; GA ČR GD522/08/H003; GA ČR(CZ) GA522/08/0920
Výzkumný záměr: CEZ:AV0Z50380511
Klíčová slova: Cytokinins * Nucleotides * HPLC
Kód oboru RIV: EB - Genetika a molekulární biologie
Impakt faktor: 3.841, rok: 2010

We describe here a new reversed phase high performance liquid chromatography with mass spectrometry detection method for quantifying intact cytokinin nucleotides in human K-562 leukemia cells. Tandem mass spectrometry (MS/MS) was used to identify the intracellular metabolites (cytokinin mono- di- and tri-phosphorylated nucleotides) in riboside-treated cells. For the protein precipitation and sample preparation, a trichloroacetic acid extraction method is used. Samples are then back-extracted with diethyleter, lyophilized, reconstituted and injected into the LC system. Analytes were quantified in negative selected ion monitoring (SIM) mode using a single quadrupole mass spectrometer. The method was validated in terms of retention time stabilities, limits of detection (LOD), linearity, recovery and analytical accuracy. The developed method was linear in the range of 1-1000 pmol for all studied compounds. The limits of detection for the analytes vary from 0.2 to 0.6 pmol.
Trvalý link: http://hdl.handle.net/11104/0190862